Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique used in radiology to generate detailed pictures of internal structures and physiological processes within the body[1][4][5]. MRI employs strong static and gradient magnetic fields along with radiofrequency waves to excite hydrogen nuclei, primarily in water and fat, and then detects the resulting signal to form high-resolution images[1][3][6]. Unlike X-ray and CT scanning, MRI does not use ionizing radiation[1][4][5]. Applications include diagnosis, staging, and follow-up for numerous diseases, especially neurological, musculoskeletal, and cardiovascular conditions[2][4][5][6]. While not a biological target, MRI can utilize contrast agents such as gadolinium-based drugs to improve imaging in certain cases[3][6]. Notable safety concerns relate to magnetic fields' interactions with implants, heating effects, and contrast agent toxicity in vulnerable populations[6].
Contrast agents: alter local magnetic properties to enhance image contrast in target tissues[3]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic resonance imaging (MRI).